It was observed that the gene with the highest mutation rate was TP53 in HNSCC patients regardless of the high GRGPI group or the low GRGPI group, suggesting that the mutations of the tumor suppressor gene TP53 may have potential clinical and pathophysiological significance in HNSCC patients. Here, TP53 is linked to head and neck squamous cell carcinoma.